Whole Blood Point of Care Metabolic Measurement

家长助学金：HD107897 PA-21-345长期调查人员行政副刊 项目摘要 Sequitur Health Corp.正在为美国国立卫生研究院第二阶段小企业进行研究 创新研究(SBIR)母公司拨款：HD107897开发用于测量 直接从一滴全血中提取分析物。Sequitur系统对此的测量准确率为90% 分析物与美国食品和药物管理局批准的临床实验室仪器方法的比较 测量这种分析物。 Sequitur Health Corp.是一家由女性拥有的小企业，由一名来自 美国小企业协会(U.S.SBA)定义的社会弱势群体。 Sequitur将利用这一补充条款聘请一名来自社会弱势群体的具有博士水平的西班牙裔女性 由美国SBA定义的集团。这位长期的调查员将为完成父母的工作做出贡献 第二阶段SBIR奖正在进行的研究目标。这一行政补充的直接影响将是 以增加美国小企业劳动力的多样性。这一行政管理的长期影响 补充将帮助受雇的个人为正在进行的研究做出贡献，发展更多的技能，以及 作为一名有创业精神的独立科学家开始成功的职业生涯。

Parent Grant: HD107897 PA-21-345 Administrative Supplement for Long-Term Investigator Project Summary Sequitur Health Corp. is performing research for a National Institutes of Health Phase II Small Business Innovation Research (SBIR) Parent Grant: HD107897 to develop a point of care system for measurement of an analyte directly from a drop of whole blood. The Sequitur system has >90% accuracy for measurement of this analyte compared to the U.S. Food and Drug Administration approved clinical laboratory instrument method for measuring this analyte. Sequitur Health Corp. is a women-owned small business that is partially owned by a female from a socially disadvantaged group, as defined by the United States Small Business Association (U.S. SBA). Sequitur will use this supplement to hire a Ph.D.-level Hispanic female, who is from a socially disadvantaged group as defined by the U.S. SBA. This Long-Term Investigator will contribute to the completion of the parent Phase II SBIR award ongoing research Aims. The immediate impact of this administrative supplement will be to increase diversity in the United States Small Business workforce. The long-term impact of this administrative supplement will be to help the individual hired contribute to the ongoing research, develop more skills, and launch a successful career as an entrepreneurial-minded independent scientist.